|
|
||||||||
Received July 29, 2003. Accepted for publication November 9, 2003.
Acknowledgment: We are indebted to Stephen Beverley (Washington University, St. Louis, MO) for plasmid pXG-GFP.
Authors addresses: Corresponding author: Neeloo Singh, Division of Biochemistry, Central Drug Research Institute, Lucknow, India, Telephone: 91-522-212-41118, Fax: 91-522-222-3405, E-mail: neeloo888{at}yahoo.com. Anuradha Dube, Division of Parasitology, Central Drug Research Institute, Lucknow, India.
This article has been cited by other articles:
![]() |
N. Singh, R. Gupta, A. K. Jaiswal, S. Sundar, and A. Dube Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening J. Antimicrob. Chemother., August 1, 2009; 64(2): 370 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Misra, A. Kumar, P. Khare, S. Gupta, N. Kumar, and A. Dube Pro-apoptotic effect of the landrace Bangla Mahoba of Piper betle on Leishmania donovani may be due to the high content of eugenol J. Med. Microbiol., August 1, 2009; 58(8): 1058 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Mehta, R. Huang, M. Yang, X.-Q. Zhang, B. Kolli, K.-P. Chang, R. M. Hoffman, Y. Goto, R. Badaro, and R. T. Schooley Real-Time In Vivo Green Fluorescent Protein Imaging of a Murine Leishmaniasis Model as a New Tool for Leishmania Vaccine and Drug Discovery Clin. Vaccine Immunol., December 1, 2008; 15(12): 1764 - 1770. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |